What if women could know — years in advance — when perimenopause and menopause will begin?

In this episode of Boombostic Health, host Bradley Bostic talks with Nich Gentry and Dr. Lizellen La Follette of Life Ahead, a groundbreaking company combining ultrasound, personalized data, and validated science to give women a clear picture of their reproductive timeline.

You'll learn:

• Why ovarian aging is the "canary in the coal mine" for overall health.

• How early menopause prediction could transform bone health, cognitive health, and preventive care.

• The science behind Life Ahead's algorithm — and why it's a breakthrough for both patients and clinicians.

• Why women's health research has been historically underfunded and how that's changing.

• The entrepreneurial challenges of building a science-backed health tech company.

Whether you're in healthcare, innovation, or simply care about the future of women's health, this conversation will leave you inspired — and rethinking what's possible in preventive care.

Listen now to learn how data, science, and proactive healthcare can rewrite the future for millions of women.

00:00 – Why Proactive Healthcare Matters Shifting from reactive to proactive care in women's health.

01:14 – Meet Life Ahead Nich and Dr. Lizellen share their mission to close the women's health gap.

04:11 – Understanding Ovarian Aging Why ovaries age faster than most organs and what it means for overall health.

08:16 – Perimenopause Explained What it is, symptoms, and why timing matters.

10:11 – The Cost of Waiting How early menopause prediction could save money and improve health outcomes.

12:41 – The Science Behind the Tool From NSF funding to Yale mathematicians — the breakthrough research journey.

14:43 – The Startup Rollercoaster Highs, lows, and challenges of building a new category in healthcare.

27:17 – WHOOP, Fitness, and Sleep Why tracking recovery and lifestyle metrics is part of better healthcare.

30:17 – Looking Ahead Envisioning the future of women's health through predictive technology.

Summary

Guest: Melissa Butterworth, CEO of Advanced Strategic Partners

Overview: Hospitals are under extreme financial pressure—but what if the answer to their budget woes is sitting right inside their own labs?

In this eye-opening episode, Melissa Butterworth—who's led over $2.4 billion in lab transactions—joins Bradley to explore the growing trend of health systems divesting lab assets. Together, they unpack:

• Why hospitals are selling even profitable lab outreach operations
• How to accurately assess the real value of a lab business
• What happens post-sale—and how to unlock even more value with AI-powered lab insights.

Chapters:

04:30 Melissa's story: from LabCorp exec to M&A powerhouse

07:20 Why lab outreach programs are being sold off—even with 40%+ margins

10:50 "Compressed value": What hospital labs are really worth to buyers like LabCorp or Quest

15:40 The rise of AI in lab-driven personalized medicine

17:45 Predicting Alzheimer's from routine labs? It's already happening.

17:55 The Role of Labs in Future Healthcare

Key Quote:

"It's just as hard to play small as it is to play big. So why not go big?" – Bradley Bostic

In this episode, host Bradley Bostic sits down with healthcare innovator and author Jim Wallace to discuss how AI, wearables, genomics, and big data are transforming the way care is delivered. Wallace shares insights from his new book, Precision Medicine, AI, and the Science of Personalized Health Care, revealing why traditional models of care are falling short—and what's next.

What you'll learn:

• Why 53% of medications don't work as intended

• How social support increases patient survival by up to 50%

• Where healthcare investment is missing the mark

• What the Alice Walton School of Medicine is doing differently

• How AI is closing critical care gaps from anemia to cancer

Chapters

00:00 Introduction to Value-Based Care and AI 04:57 The Journey to Personalized Healthcare 11:12 AI's Role in Transforming Healthcare 18:25 The Importance of Preventive Medicine 25:49 Innovations in Medical Education 33:58 The Future of Healthcare and AI

In this episode of Boombostic Health, host Bradley Bostic speaks with Greg Stein, CEO of Shadowbox, about the challenges and innovations surrounding electronic health records (EHRs) and lab test ordering. They discuss the limitations of traditional EHR systems, the innovative solutions Shadowbox provides to streamline lab test ordering, and the broader implications for diagnostics and patient care. The conversation also touches on community health initiatives, the importance of interoperability in healthcare, and the potential for partnerships to enhance healthcare delivery.

Takeaways

• The business of healthcare is fundamentally broken.
• Shadowbox offers an innovative solution for lab test ordering.
• Faxes are still prevalent in healthcare communications.
• Shadowbox has achieved a 20% reduction in denials for labs.
• The Shadowbox system can be applied to various diagnostics, not just labs.
• There is a significant opportunity to flag patients for clinical trials.
• Healthcare interoperability is a $950 billion problem.
• No single solution fits all healthcare interoperability needs.
• The time for healthcare innovation is now.
• Partnerships can enhance healthcare delivery and patient outcomes.

Chapters

00:00 Introduction to Electronic Health Records and Their Challenges

04:52 Innovative Solutions for Lab Test Ordering

09:05 Expanding Beyond Labs: Applicability to Other Diagnostics

12:22 Research Opportunities and Clinical Trials

16:22 Community Engagement and Public Health Initiatives

19:54 Understanding Interoperability and Integration Challenges

27:10 Partnerships and Future Directions in Healthcare

Episode Summary:

In this special "Best Of" episode, we bring together the boldest, most unforgettable moments from our five most-watched interviews on Boombostic Health. These leaders aren't just talking about change—they're making it happen.

In just 30 minutes, you'll hear from entrepreneurs, investors, clinicians, and health system leaders who are all challenging the business of healthcare in radically different—and deeply personal—ways.

Featured Guests:

• Chris Leeuw – After surviving a paralyzing spinal cord injury, Chris defied the odds, relearned to walk, and launched NeuroHope to build a more humane, patient-focused model of care.

• Adam Heller – Venture capitalist and founder of Oakwood Circle Ventures, Adam breaks down the economic dysfunction at the heart of healthcare and why capital must follow impact, not hype.

• Steve Serota – As a leader in lab medicine, Steve explains why treating cancer without subspecialized pathologists is a dangerous norm—and what needs to change now.

• Matt Honan – A diagnostics executive who reveals how a simple lab test can prevent costly surgical complications, while saving lives and driving smarter care.

• David Ohm – A nonprofit health system executive showing how AI can bring operational efficiency—and better care—to underserved populations, if applied with the right intent.

What You'll Learn:

• Why most spinal cord injury patients are abandoned by the system—and how NeuroHope is changing that

• The trillion-dollar inefficiencies strangling healthcare innovation

• How diagnostics can shift care from reactive to proactive

• The hidden power of pathology—and what happens when we ignore it

• Why AI in healthcare isn't just about tech—it's about equity, governance, and trust

🎧 Listen if you're ready to:

• Hear real solutions from the people building them

• Challenge your assumptions about healthcare innovation

• Get inspired by resilience, purpose, and bold leadership

In this episode, Bradley Bostic and James Maskell discuss the innovative approaches to addressing cognitive decline through functional and precision medicine. They explore the impact of environmental factors, particularly mold, on brain health, and the importance of a holistic approach to care. James shares his personal journey with his father's cognitive decline and how it led to the development of TruNeura, a revolutionary tool to allow any clinic to operate and scale a successful brain health protocol.

The conversation highlights the need for a shift in healthcare models to better support aging populations and the potential for preventive measures in cognitive health.

Watch full episode on YouTube here.

Takeaways

- Cognitive decline is a multifaceted issue influenced by environmental factors. - Mold exposure can significantly impact cognitive health. - Precision medicine offers a promising approach to reversing cognitive decline. - TruNeura aims to integrate a multimodal approach to brain health. - Holistic health programs can benefit seniors in living facilities. - The healthcare system is slowly recognizing the importance of functional medicine. - There is a growing demand for personalized cognitive health solutions. - Understanding the prodromal period is crucial for early intervention. - Community support plays a vital role in managing cognitive health. - Preventive measures can start as early as age 30.

Chapters

00:00 Introduction to Cognitive Decline Solutions 02:54 Personal Journey and Mold's Impact on Cognitive Health 06:39 Understanding Environmental Determinants of Health 09:27 The Role of Precision Medicine in Cognitive Health 13:09 Developing a Software Solution for Cognitive Care 15:32 Integrating Cognitive Health in Senior Living 18:00 Holistic Health Approach to Cognitive Decline 21:00 Challenges in Implementing New Health Models 23:49 The Future of Cognitive Health and Prevention

Summary

In this episode of Boom Bostic Health, host Bradley Bostic interviews James Maskell, a thought leader in functional medicine and health economics. They discuss Maskell's journey into the field, the challenges of conventional medicine, and the potential for reversing chronic diseases through lifestyle changes. The conversation also touches on the importance of community in health, the shift towards value-based care, and the future of cognitive health in the context of functional medicine.

Watch full episode on YouTube

Takeaways

• James Maskell's early exposure to alternative medicine shaped his career.
• The medical system is not designed for chronic disease management.
• Chronic diseases can be reversible with lifestyle changes.
• Patient empowerment is crucial in reversing chronic illnesses.
• Functional medicine focuses on the root causes of health issues.
• Community support enhances health outcomes.
• Value-based care incentivizes keeping patients healthy.
• Loneliness is a significant factor in health outcomes.
• Cognitive health can be improved with precision medicine.
• Collaboration between conventional and functional medicine is essential.

Chapters

00:00 Introduction to Functional Medicine and Longevity 02:39 James Maskell's Journey into Health Economics 05:42 Reversing Chronic Disease: A New Approach 08:23 The Evolution of Medicine and Entrepreneurial Ventures 11:06 Challenges in Conventional Medicine 13:51 Value-Based Care and Its Implications 16:43 The Role of Community in Health 19:32 Future of Cognitive Health and Functional Medicine

To learn more about James Maskell, visit his website here.

Summary

In this episode of Boombostic Health, Bradley Bostic and Brent Bolton discuss the transformative potential of agentic AI in healthcare, particularly in improving supply chain efficiency. They explore the tactical nature of healthcare supply chains, the impact of AI on forecasting and inventory management, and the importance of leveraging data for better decision-making.

The conversation also highlights the significant cost savings achieved through effective supply chain management and the collaborative opportunities that arise from partnerships between healthcare systems and suppliers. As they conclude, they reflect on the future of healthcare supply chains and the role of technology in driving improvements.

Takeaways

• Agentic AI holds great promise for healthcare efficiency.
• Healthcare supply chains are often managed in a tactical manner.
• AI can significantly enhance supply chain operations.
• The pandemic highlighted the fragility of supply chains.
• 3D printing may revolutionize healthcare supply logistics.
• Data is crucial for effective supply chain management.
• Benchmarking against industry standards is essential.
• Over $100 million has been saved through improved supply chain practices.
• Collaborative negotiations can benefit both healthcare systems and suppliers.
• AI will play a key role in streamlining procurement processes.

Chapters

00:00 Introduction to Agentic AI in Healthcare 04:33 The Role of Supply Chain in Healthcare 10:45 Impact of AI on Supply Chain Efficiency 16:13 Leveraging Data for Better Supply Chain Management 20:02 Cost Savings and Collaborative Opportunities in Healthcare 24:00 Conclusion and Future of Healthcare Supply Chain

Summary

In this episode of Boombostic Health, Bradley Bostic interviews Val Adia, CEO of BocaBiolistics, discussing his journey in the healthcare industry, the importance of biobanks in accelerating research, and the future of personalized medicine.

Val shares insights on the role of genomics, the transition from large enterprises to startups, and the unique global capabilities of BocaBiolistics. The conversation emphasizes the need for a preventative approach in healthcare and the potential for improved patient outcomes through innovative technologies.

Watch full episode on YouTube

Takeaways

• Val Adia's journey in healthcare began at the New York Blood Center.
• BocaBiolystics focuses on accelerating research for new therapeutics.
• The company has a global scope in specimen collection.
• Personalized medicine is becoming increasingly important in treatment efficacy.
• The pandemic highlighted weaknesses in healthcare delivery.
• BocaBiolistics supports both diagnostic and pharmaceutical research.
• AI and technology are crucial for analyzing patient data.
• The future of healthcare is moving towards preventative measures.
• Val's passion for oncology drives BocaBiolistics' mission.

Chapters

00:00 Introduction to BocaBiolystics and Val's Journey 02:57 The Role of Biobanks in Accelerating Research 05:50 Personalized Medicine and Genomics 08:47 Transitioning from Large Enterprises to Startups 12:04 The Future of Healthcare and Technology 15:02 Global Scope and Unique Capabilities of BocaBiolystics 19:04 Vision for the Future of BocaBiolystics and Personalized Medicine

Summary

In this episode of Boombostic Health, Bradley Bostic interviews Dustin Suntheimer, Director of Commercial Operations in diagnostics, to discuss the advancements in oncology testing and the impact of genetic profiling on cancer treatment.

They explore the evolution of cancer diagnostics, the significance of omics, and the role of advanced genetic testing in personalizing treatment plans. The conversation also touches on the accessibility of these tests across different demographics and the future of cancer care, emphasizing the importance of collaboration between healthcare providers and laboratories.

Watch full episode on YouTube here

Takeaways

• The state of oncology testing has significantly improved over the years.
• Advanced molecular assays can lead to better patient outcomes.
• Digital pathology allows for remote examination of tissue samples.
• Genetic testing can help eliminate ineffective treatments.
• Molecular profiling is essential for personalized cancer therapy.
• Omics encompasses various fields that enhance our understanding of biology.
• Precision medicine tailors treatment based on individual genetic profiles.
• Genetic testing should be accessible to all patients, regardless of socioeconomic status.
• Healthcare providers must be aware of genetic testing guidelines.
• Collaboration between physicians and laboratories is crucial for patient care.

Chapters

00:00 Introduction to Oncology Testing and Its Evolution 03:01 Understanding Anatomic Pathology and Molecular Testing 06:00 The Importance of Genetic Profiling in Cancer Treatment 08:55 The Role of Omics in Cancer Diagnostics 11:52 Advanced Technologies in Cancer Testing 14:54 The Impact of Genetic Testing on Preventative Care 17:49 Tracking Cancer Recurrence with Advanced Testing 21:00 The Importance of Family History in Cancer Risk 24:05 Guidelines for Genetic Testing and Preventative Measures 26:55 Healthcare Innovation and the Future of Cancer Treatment 29:55 The Socioeconomic Factors in Accessing Genetic Testing 33:08 Conclusion and Future Directions in Oncology